日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

AMPK-activated BAP1 regulates pVHL stability and tumor-suppressive functions

AMPK激活的BAP1调节pVHL的稳定性和抑癌功能

Li, Mei; Huang, Lei; Chen, Jiayi; Guan, Tangming; Wen, Yalei; Zhu, Yingjie; Yang, Xiao; Zhang, Caishi; Ma, Xiuqing; Wan, Rui; He, Yuanqiao; Zhou, Yang; Song, Yan; Zhang, Haoxing; Liu, Tongzheng

UFMylation maintains tumor suppressor pVHL stability by activating the deubiquitinase BAP1.

UFMylation 通过激活去泛素化酶 BAP1 来维持肿瘤抑制因子 pVHL 的稳定性

Yang Xiao, Wen Yalei, Qin Shengying, Zhou Yang, Zhang Caishi, Huang Lei, Li Mei, Ma Xiuqing, Wan Rui, Chen Jiaqi, He Rong-Rong, Gao Hao, Goding Colin R, Luo Oscar Junhong, Shen Xiangchun, Cui Rutao, Liu Tongzheng

Phosphorylation of USP33 by CDK1 stabilizes the mTORC2 component SIN1.

CDK1 对 USP33 的磷酸化可稳定 mTORC2 组分 SIN1

Wen Yalei, Zhang Caishi, Liang Mingchao, Yang Xiao, Zeng Hu, Wan Rui, Ma Xiuqing, Huang Lei, Li Mei, Zhang Qiushi, Li Liheng, Qin Shengying, Liu Tongzheng

CK2α-mediated phosphorylation of DUB3 promotes YAP1 stability and oncogenic functions.

CK2α介导的DUB3磷酸化促进YAP1的稳定性和致癌功能

Huang Lei, Wen Yalei, Guo Qin, Zhang Caishi, Yang Xiao, Li Mei, Liu YiXia, Li Xinying, Tang Jiaxin, Zhou Xiaofeng, Qi Qi, Zhang Haoxing, Liu Tongzheng

High-throughput discovery of highly selective reversible hMAO-B inhibitors based on at-line nanofractionation

基于在线纳米分级分离的高通量发现高选择性可逆hMAO-B抑制剂

Fan, Yu; Wang, Jincai; Jian, Jingyi; Wen, Yalei; Li, Jiahao; Tian, Hao; Crommen, Jacques; Bi, Wei; Zhang, Tingting; Jiang, Zhengjin

Chronic inflammation, cancer development and immunotherapy

慢性炎症、癌症发展和免疫疗法

Wen, Yalei; Zhu, Yingjie; Zhang, Caishi; Yang, Xiao; Gao, Yuchen; Li, Mei; Yang, Hongyan; Liu, Tongzheng; Tang, Hui

Transcriptional network constituted of CBP, Ku70, NOX2, and BAX prevents the cell death of necrosis, paraptosis, and apoptosis in human melanoma

由CBP、Ku70、NOX2和BAX组成的转录网络可阻止人类黑色素瘤细胞发生坏死、副凋亡和凋亡。

Ding, Liang; Wen, Yalei; Zhang, Xin; Zhao, Fang; Lv, Kenao; Shi, Jian-Hong; Shen, Shigang; Pan, Xuefeng